A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003-2004 and 2004-2005 Influenza Seasons-Reference-Cited by-同舟云学术

A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003-2004 and 2004-2005 Influenza Seasons

Published:2006-08-15 Issue:4 Volume:43 Page:439-444
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Kawai N.,Ikematsu H.,Iwaki N.,Maeda T.,Satoh I.,Hirotsu N.,Kashiwagi S.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/43/4/439/1097655/43-4-439.pdf

Reference20 articles.

1. Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002--2003 Influenza Season

2. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

3. Influenza virus neuraminidase inhibitors

4. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

5. Oseltamivir

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Three-Dimensional Reference Interaction Site Model Approach as a Promising Tool for Studying Hydrated Viruses and Their Complexes with Ligands;International Journal of Molecular Sciences;2024-03-26

2. Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients;Transplant Infectious Disease;2024-02-06

3. Murine Broadly Reactive Antineuraminidase Monoclonal Antibodies Protect Mice from Recent Influenza B Virus Isolates and Partially Inhibit Virus Transmission in the Guinea Pig Model;mSphere;2022-10-26

4. Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children;Frontiers in Pharmacology;2022-04-06

5. Targeted inhibition of the endonuclease activity of influenza polymerase acidic proteins;Future Medicinal Chemistry;2022-04